A “messy” gap
According to the South China Morning Post, scientists still do not fully understand why women make up the majority of Alzheimer’s cases. Dr Emily Gordon of the University of Queensland acknowledges that the picture is complex.
Sex differences in dementia are not straightforward. It’s messy.
For years, the most common explanation was that women live longer and so have more time to develop the disease. But recent epidemiological data show the story does not end with longevity: women run a higher risk of mild cognitive impairment between the ages of 55 and 70, and of Alzheimer’s between 65 and 75.
Oestrogen, menopause and the brain’s “energy crisis”
Oestrogen is not only a reproductive hormone but also a brain hormone. As women enter perimenopause and menopause, oestrogen levels fall, and many experience forgetfulness, difficulty concentrating or trouble finding words. In some, the transition also triggers a kind of energy crisis in the brain that may precipitate degeneration. Studies have linked several reproductive factors to risk:
- Early menopause, especially before age 45, is linked with a higher risk of dementia.
- Removal of the ovaries before natural menopause may raise long-term risk.
- A shorter reproductive span, meaning less exposure to oestrogen, is also thought to play a role, though findings remain mixed.
Experts stress that menopause does not cause Alzheimer’s, but without oestrogen’s neuroprotective effects, a woman’s brain becomes more vulnerable to age-related stressors.
The APOE4 gene hits women harder
APOE4 is the main genetic risk factor for Alzheimer’s. In women, it is a stronger risk factor than in men between the ages of 65 and 75.
Research using UK Biobank data also found that APOE4 is associated with early menopause, and that women who carry the gene and experience early menopause have the highest risk.
“The higher dementia prevalence among women may be tied to the effects of menopause on brain metabolism and the impact of the main genetic risk factor APOE4 being greater in women.” – Anne-Marie Minihane, University of East Anglia
In addition, at the same level of amyloid build-up, women tend to show more tau protein than men, an important pathological marker of Alzheimer’s.
Hormone therapy: hope and caution
A study published in Alzheimer’s & Dementia in 2026 found that using hormone replacement therapy for at least one year was associated with about a 10% lower risk of dementia, with stronger effects among women who had surgical menopause or carried APOE4. However, the study does not prove causation.
Timing appears to be crucial. The WHIMS trial found that starting hormone therapy at ages 65 to 79 raised the risk of dementia. Current guidelines do not recommend hormone therapy to prevent dementia in the general population, and women should talk to their doctor before making any decision.
The midlife window to act
Alzheimer’s-related brain changes develop over a preclinical phase of 10 to 20 years that begins in midlife. Researchers therefore see midlife as a critical window for intervention to prevent or delay the disease.
Beyond hormones, familiar habits still matter: controlling blood pressure, cholesterol and blood sugar, exercising regularly, staying socially connected, and caring for hearing and mental health. Depression, which is common during menopause, is also a risk factor that deserves attention. Nothing is guaranteed, but every small step today can help protect tomorrow’s memory.
















